Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Postoperative Cognitive Function
NCT00561678Phase 4Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Feb 2008
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative delirium (POD) and Post-operative cognitive dysfunction (POCD) comparing Precedex with Placebo (2 arms). Primary endpoint: Delirium Battery at Day 1. Started Feb 2008; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT00561678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00561678.